ReNerve Quarterly Investor Update

Development of Novel Nerve Repair & Regeneration Products
ReNerve is focused on developing a portfolio of products for the nerve repair and regeneration markets, with clearly defined commercial demand.
Significant Product Portfolio
ReNerve currently has one product in market with a clear commercial pathway for FDA approval of 3+ products over the next 4 years.
Strong Sales & Distribution Presence
ReNerve have established logistics, warehouse and invoicing infrastructure with a strong focus on building a sales distribution network for all products.